Subject: Pharmaceuticals

End of Life Care, Pharmaceuticals

The Code Blue Pharmacist 

A patient coded at my hospital without having clear guidelines about what he wanted for treatment plan. It left the hosp...

May 13, 2022

Pharmaceuticals, Public Health

Ethically Allocating COVID-19 Drugs Via Pre-approval Access and Emergency Use Authorization

Abstract Allocating access to unapproved COVID-19 drugs available via Pre-Approval Access pathways or Emergency Use Auth...

Clinical Trials & Studies, COVID-19 pandemic, Decision making, Global Ethics, Pharmaceuticals, Vaccines

AstaZeneca’s Vaccine Ethical Problem

Brian M. Cummings, MD and John J. Paris, SJ, PhD In The New York Times, almost overlooked amidst multiple arti...

March 29, 2021

Pharmaceuticals, Public Health

Ethically Allocating COVID-19 Drugs Via Pre-approval Access and Emergency Use Authorization

Abstract Allocating access to unapproved COVID-19 drugs available via Pre-Approval Access pathways or Emergency Use Auth...

Pharmaceuticals, Research Ethics

The Limits of Individualism: Potential Societal Harms from the EAP for Convalescent Plasma

Abstract This issue features a set of articles addressing allocation issues for drugs for COVID-19 that have not been ap...

Clinical Trials & Studies, Pharmaceuticals, Science

Vaccine Approval and Public Trust: The Dynamic Factors Influencing When a COVID-19 Vaccine...

by Berklee Robins, MD, MA & Ashley Sweet, MD, MBE Vaccines are approved when it is clear that the benefits to the in...

October 14, 2020

Health Regulation & Law, Pharmaceuticals, Public Health

Emergency Use Authorization for Covid-19 Vaccines: Lessons from the Past

by Dorit Reiss, PhD LLB, Art Caplan, PhD, and Working Group on Vaccine Ethics and Policy The question whether the F...

October 6, 2020

Health Regulation & Law, Human Subjects Research & IRBs, Pharmaceuticals

Statement of Support for the FDA

The Working Group on Compassionate Use and Preapproval Access (CUPA), a project of the NYU Grossman School of Medicine D...

September 11, 2020

Informed Consent, Pediatrics, Pharmaceuticals, Professional Ethics, Professionalism

Shared Decision Making with Pediatric Medications

by Amy C. Reese, Pharm.D. My pharmacy received a prescription for prednisolone solution written for a 5-year-old patient...

July 6, 2020

Clinical Trials & Studies, Pharmaceuticals, Politics

The COVID-19 Pandemic and the Problem of Pseudoscience

by Kiarash Aramesh M.D., Ph.D. The COVID-19 pandemic has been accompanied by a surge of pseudoscientific claims, sometim...

June 2, 2020

Clinical Trials & Studies, Ethics, Health Care, Health Policy & Insurance, Human Subjects Research & IRBs, Informed Consent, Pharmaceuticals, Politics, Public Health

My Experiences with Hydroxychloroquine Urge Caution and Ethical Research into COVID19 Ther...

by Keisha Ray, Ph.D. I take the drug hydroxychloroquine, brand name Plaquenil, for an autoimmune disease. Hydroxychloroq...

April 20, 2020

Clinical Trials & Studies, Pharmaceuticals, Professional Ethics, Public Health

The Real Question on the Hydroxychloroquine Mystery: Why are Doctors Prescribing It?

by Craig Klugman, Ph.D. On March 31, the U.S. Department of Justice put in an order for $60,000 worth of hydroxychloroqu...

April 10, 2020

View more

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Privacy Policy. By closing this message, you are consenting to our use of cookies.